Please sign in to follow a disease.
Cuddle care: could a simple side hold help preemies on ventilators?
NCT ID NCT07428408
First seen Jun 27, 2026 · Last updated Aug 12, 2026 · Updated 2 times
Summary
This study will test whether placing a newborn on their mother's chest in a side-lying 'kangaroo' position can improve comfort and vital signs during noninvasive breathing support. Researchers plan to enroll 92 premature infants (32-36 weeks) receiving nCPAP. Half will receive the side kangaroo position, and half will receive standard care. Comfort levels, heart rate, breathing rate, and oxygen levels will be compared before, during, and after the procedure.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- side kangaroo position (a care procedure where the baby is placed diagonally on the mother's bare chest)
- What this could lead to
- If it works, this simple position change could become a standard way to make breathing support more comfortable and stable for premature babies.
- What could go wrong
- This is a small, early-stage study with only 92 infants. The results may not apply to all newborns, and the position may not significantly improve comfort or vital signs.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 92 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Aug 2026
An estimate. Start dates often move.
- Expected to finish
-
Nov 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
1 day to 1 month
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Gestational age between 32 and 36 weeks * No congenital anomalies * No issues preventing positioning * No infection Exclusion Criteria: * Gestational age greater than 37 weeks * With neurological problems * With immune system problems * Receiving sedative medication * With signs of meconium aspiration syndrome * With low Apgar scores (1-minute Apgar score: 0-3) * Newborns requiring intubation
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Newborn care are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Tarsus University
Mersin, 33400, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.